Document is current
Any future updates will be listed below
-
Authors
Jakobs, Florian
Jeck, Julia
Ahmadi, Paymon
Kron, Anna
Kron, Florian
-
Funding
Funding for this research was provided by:
Gilead Sciences
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 19 November 2021
Accepted: 11 November 2022
First Online: 12 December 2022
Declarations
:
: Due to the retrospective study design and a pseudonymised documentation of underlying cost data, no ethical vote was needed.
: Not applicable.
: F. Jakobs has nothing to disclose. J. Jeck has nothing to disclose. P. Ahmadi has nothing to disclose. A. Kron received consultancy honoraria from Takeda, BMS, AbbVie, Novartis, and MSD. F. Kron received lecture honoraria and/or advisory board and consultancy honoraria from Pfizer Inc, MSD, Bristol Myers Squibb, Novartis, Takeda, Amgen, Janssen-Cilag, Gilead Sciences Inc, Bayer, Mundipharma, Riemser, Medac, Jazz Pharmaceuticals, Servier, Cerus, Abbvie.
